Indications
Palforzia is indicated for the treatment of patients aged 1 to 17 years with a confirmed diagnosis of peanut allergy. Palforzia may be continued in patients 18 years of age and older. Palforzia should be used in conjunction with a peanut-avoidant diet.
Composition
- Active substance
- defatted powder of Arachis hypogaea L., semen (peanuts)
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Palforzia
- Active substance
- defatted powder of Arachis hypogaea L., semen (peanuts)
- ATC code
- V01
- Group
- Various
- Therapeutic area
- Peanut Hypersensitivity
- Marketing authorisation holder
- Stallergenes